Aragon Burlingham – Founder and President & interim Secretary has spent the past decade in Silicon Valley in executive management positions at a diverse range of companies taking products from concept to production. He has a multidisciplinary engineering background, touching on fluid mechanics, structures, controls, and mathematical modeling.Throughout his college education and career, Aragon has worked with local schools in a volunteer capacity focusing on Math and Science education. Aragon switched careers in early 2008 to focus on his life long passion to enhance the math and science learning experiences of children. After spending an invaluable six months volunteering in local schools, he decided to launch the We Teach Science Foundation to empower engineers and scientists to assist and work with math and science teachers and students. Prior to forming the We Teach Science Foundation, Aragon served as President of D2M, a product design consultancy in Silicon Valley. Preceding D2M, he was Director of Operations at Speck Product Design, where he managed engineering operations in the Palo Alto and Shanghai offices. Aragon spent six years at RoboToolz, a manufacturer of laser-based measuring tools for the construction industry, managing R&D operations for products from concept development through design and transition to mass production in China. Aragon has a Master of Science in Aeronautics & Astronautics from Stanford University, and a Bachelor of Science in Aerospace Engineering from the University of Southern California.
David N. Low – CFO/Treasurer has worked as an investment banker since 1987, focusing on the life sciences sector and emerging growth companies. Since 2002, he has been a member of Lazard’s Life Sciences Group as a Managing Director based in San Francisco. Mr. Low has advised on major M&A transactions in the life sciences sector and has worked with private and public companies on capital raising. Prior to joining Lazard, Mr. Low was a Managing Director at JP Morgan and also worked at Lehman Brothers. Mr. Low also serves on the Regional Advisory Board of the Institute of International Education West Coast Center and on the Board of Directors for Lets Be Frank Dogs. Mr. Low holds an AB from Harvard College, an MA from Johns Hopkins University and an MBA from Yale University.
Stephen Sulzbacher, Ph.D. is an Emeritus Associate Professor of Pediatrics and Psychiatry at the University of Washington School of Medicine. He was a pioneer in developing telemedicine and distance learning technology for rural schools and clinics in the Pacific Northwest. He is the author of educational software programs and was a founding director of the Edmark Corp. He has been a frequent consultant on neurological problems of children at the National Institutes of Health, and for the Office of Special Education & Rehab. Services of the US Department of Education. Currently, Dr. Sulzbacher teaches courses in Global Health policy and continues his clinical work on inherited metabolic diseases and brain development.
Tina Cheuk is the Project Manager for a national language and literacy initiative building on the Common Core State Standards and the Next Generation of Science Standards based out of Stanford University. She was formerly the Assistant Director of the San Francisco Field Site for Strategic Education Research Partnership (SERP). She is a Teach for America alumna who taught middle school science and language arts at the Knowledge Is Power Program (KIPP) Academy in the South Bronx, NY and founded KIPP King Collegiate High School as a Dean in the East Bay, CA. She is a returned Peace Corps volunteer and worked as a high school science teacher and teacher trainer in Ghana, West Africa. Tina has also been a research assistant at the Center for Urban School Improvement in Chicago where she studied how technology tools supported teaching and learning at the University of Chicago affiliated charter schools. She holds a B.S. in Chemistry and Biochemistry from the University of Chicago and an M.A. in Education from Stanford University.
Dr. Susan Molineaux is a co-founder of Calithera Biosciences and has served as the company’s Chief Executive Officer since the company’s founding in June 2010. Dr. Molineaux was most recently a founder, CSO and CEO of Proteolix, a company that discovered and developed proteasome inhibitors for the treatment of cancer and autoimmune disease. Prior to joining Proteolix, Dr. Molineaux was Vice President, Biology at Rigel Pharmaceuticals from 2000 to 2003. Before that, she was Vice President, Biology at Praelux, and from 1994 through 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals. From 1989 until 1994 she was a scientist in the Immunology group at Merck, in Rahway, NJ. Dr. Molineaux received a B.S. degree in Biology from Smith College, a Ph.D. degree in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.